Delivery Order SPE2DB22D2206-SPE2DB24FKH52
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,560.80 firm fixed-price delivery order is for the drug IBSRELA 50 MG TABLET, with a completion date of January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.94, is a firm fixed-price delivery order for the supply of IBSRELA 50 MG TABLET UU 60S, a medical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,363.49 firm fixed-price delivery order covers the supply of IBSRELA 50 MG TABLET, a pharmaceutical product, to support military healthcare programs. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IBSRELA 50 MG TABLET UU 60S. The contract has a ceiling value of $21,086.53 and a completion date of January 2, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of IBSRELA 50 MG TABLET. The $9,614.18 Firm Fixed Price contract has an ultimate completion date of March 21, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $13,341.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBSRELA 50 MG TABLET, a pharmaceutical product, with a completion date of May 8, 2025. The contract is a Firm Fixed Price Delivery Order, and it is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $46,500.43 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of IBSRELA 50 MG TABLET in quantities of 60s, and has a completion date of February 16, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $17,788.58 for the provision of 4566976306 - IBSRELA 50 MG TABLET UU 60S. The award was issued by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of January 21, 2025. AmerisourceBergen Drug Corp is the prime contractor for this firm fixed-price contract and there is no set-aside designation. The company also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,122.54 firm fixed-price contract is for the supply of IBSRELA 50 MG TABLET UU 60S medical products. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 24, 2025. This award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $4,226.33, is for the delivery of IBSRELA 50 MG TABLET medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...